Your browser doesn't support javascript.
loading
Classification Criteria for Axial Disease in Youth with Juvenile Spondyloarthritis.
Weiss, Pamela F; Brandon, Timothy G; Aggarwal, Amita; Burgos-Vargas, Ruben; Colbert, Robert A; Horneff, Gerd; Laxer, Ronald M; Minden, Kirsten; Ravelli, Angelo; Ruperto, Nicolino; Smith, Judith A; Stoll, Matthew L; Tse, Shirley M; Van den Bosch, Filip; Maksymowych, Walter P; Lambert, Robert G; Biko, David M; Chauvin, Nancy A; Francavilla, Michael L; Jaremko, Jacob L; Herregods, Nele; Kasapcopur, Ozgur; Yildiz, Mehmet; Srinivasalu, Hemalatha; Lovell, Daniel J; Nigrovic, Peter A; Foeldvari, Ivan; Klein-Gitelman, Marisa S; Ozen, Seza; Naden, Ray; Hendry, Alison M; Joos, Rik.
Afiliación
  • Weiss PF; Department of Pediatrics, Division of Rheumatology and Clinical Futures, Children's Hospital of Philadelphia and Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Brandon TG; Department of Pediatrics, Division of Rheumatology and Clinical Futures, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Aggarwal A; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Burgos-Vargas R; Department of Rheumatology, Hospital General de Mexico Dr Eduardo Ligeaga, Mexico.
  • Colbert RA; National Institute of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Horneff G; Department of General Paediatrics, Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany.
  • Laxer RM; Department of Pediatric and Adolescent Medicine, University Hospital Cologne, Cologne, Germany.
  • Minden K; Professor of Pediatrics and Medicine, University of Toronto, Staff Rheumatologist, The Hospital for Sick Children and St. Michael's Hospital.
  • Ravelli A; 1- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Berlin, Germany.
  • Ruperto N; 2 - Deutsches Rheuma-Forschungszentrum Berlin, Germany.
  • Smith JA; Direzione Scientifica, IRCCS Istituto Giannina Gaslini and Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università degli Studi di Genova, Genoa, Italy.
  • Stoll ML; IRCCS Istituto Giannina Gaslini, Gaslini Trial Centre/Servizio di Sperimentazioni Cliniche Pediatriche, PRINTO, Genova, Italy.
  • Tse SM; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
  • Van den Bosch F; Department of Pediatrics, University of Alabama at Birmingham; Birmingham, AL, USA.
  • Maksymowych WP; Department of Paediatrics, Division of Rheumatology, The Hospital for Sick Children (SickKids), University of Toronto, Toronto, ON, Canada.
  • Lambert RG; VIB-UGent Center for Inflammation Research, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.
  • Biko DM; Professor of Medicine, Department of Medicine, University of Alberta and Chief Medical Officer, CARE Arthritis, Edmonton, AB, Canada.
  • Chauvin NA; Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.
  • Francavilla ML; Department of Radiology, Children's Hospital of Philadelphia and Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Jaremko JL; Department of Radiology, Penn State Health Milton S. Hershey Children's Hospital, Hershey, PA, USA.
  • Herregods N; Department of Radiology, Whiddon College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Kasapcopur O; Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.
  • Yildiz M; Department of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
  • Srinivasalu H; Department of Pediatric Rheumatology, Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Turkey.
  • Lovell DJ; Department of Pediatric Rheumatology, Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Turkey.
  • Nigrovic PA; Division of Rheumatology, Children's National Hospital, George Washington University School of Medicine, Washington, DC, USA.
  • Foeldvari I; Pediatric Translational Research Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Klein-Gitelman MS; Division of Rheumatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
  • Ozen S; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Naden R; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hendry AM; Hamburg Centre for Paediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany.
  • Joos R; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Arthritis Rheumatol ; 2024 Jul 22.
Article en En | MEDLINE | ID: mdl-39039899
ABSTRACT

OBJECTIVES:

To develop and validate classification criteria for axial disease in youth with juvenile spondyloarthritis (SpA; AxJSpA).

METHODS:

This international initiative consisted of four phases 1) Item generation; 2) Item reduction; 3) Criteria development; and 4) Validation of the AxJSpA criteria by an independent team of experts in an internationally representative Validation cohort.

RESULTS:

These criteria are intended to be used on youth with a physician diagnosis of juvenile SpA and for whom axial disease is suspected. Item generation consisted of a systematic literature review and a free-listing exercise using input from international physicians and collectively resulted in 108 items. After the item reduction exercise and expert panel input, 37 items remained for further consideration. The final AxJSpA criteria domains included imaging active inflammation, imaging structural lesions, pain chronicity, pain pattern, pain location, stiffness, and genetics. The most heavily weighted domains were active inflammation and structural lesions on imaging. Imaging typical of sacroiliitis was deemed necessary, but not sufficient, to classify a youth with AxJSpA. The threshold for classification of AxJSpA was a score of ≥55 (out of 100). When tested in the validation data set, the final criteria had a specificity of 97.5% (95% CI 91.4-99.7), sensitivity of 64.3% (95% CI 54.9-73.1) and Area Under the Receiver Operating Characteristic (AUROC) curve of 0.81 (95% CI 0.76-0.86).

CONCLUSIONS:

The new AxJSpA classification criteria require an entry criterion, physician diagnosis of juvenile SpA, and include seven weighted domains. The AxJSpA classification criteria are validated and designed to identify participants for research studies.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Arthritis Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Arthritis Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos